Ying-Jie Jiang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Induced Pluripotent Stem Cells

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Wang, Ye-Chen Xia, Bao-Xing Tian, Ju-Tang Li, Heng-Yu Li, Hui Dong, Xiao-Guang Li, Hua Yu, Yu-Yao Zhu, Jun Ma, Ying-Jie Jiang, Guang-Zhi Jin
Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer. Cancer 130 (S8) (2024)
Jie Wang, Ye-Chen Xia, Bao-Xing Tian, Ju-Tang Li, Heng-Yu Li, Hui Dong, Xiao-Guang Li, Hua Yu, Yu-Yao Zhu, Jun Ma, Ying-Jie Jiang, Guang-Zhi Jin
Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer. Cancer 130 (S8) (2024)
Jie Wang, Ye-Chen Xia, Bao-Xing Tian, Ju-Tang Li, Heng-Yu Li, Hui Dong, Xiao-Guang Li, Hua Yu, Yu-Yao Zhu, Jun Ma, Ying-Jie Jiang, Guang-Zhi Jin
Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer. Cancer (2024)